印度尼西亚
越南
印度
菲律宾
土耳其
美国
墨西哥
加拿大
危地马拉
歌诗达黎加
阿根廷
巴西
智利
哥伦比亚
秘鲁
俄罗斯
乌克兰
法国
德国
意大利
埃塞俄比亚
乌干达
博茨瓦纳
加纳
肯尼亚
澳大利亚
新西兰
斐济
维尔京群岛
关岛
| 电子邮件 | ema***@***.com | 获取Email |
|---|
| 电子邮件 | ema***@***.com | 获取Email |
|---|
At embecta (formerly part of BD) we are a global medical technology company singularly focused on improving the lives of people living with diabetes. For nearly 100 years, we've been developing and providing solutions to the diabetes community. We are the leaders in insulin delivery, with more than 30 million people in over 100 countries relying on our pen needle and syringe products. BD is the manufacturer of the advertised products. Privacy Policy: https://www.embecta.com/en-us/about/policies/privacy-policy-statement
| 公司 | embecta |
|---|---|
| 职位 | Director, R&D-Electrical Engineering |
| 地点 | United States |
| http://www.linkedin.com/in/ron-moulton | |
| 部门 | master_engineering_technical,master_information_technology |
| 头衔 | Director, R&D-Electrical Engineering |
embecta Director, R&D-Electrical Engineering
2022-04-01 -
Associate Director, R&D-Electrical Engineering
2020-04-01 - 2022-04-01
NinePoint Medical, Inc. Director of R&D, Electrical Engineering
2018-10-01 - 2020-03-01
NinePoint Medical, Inc. Principal Electrical Engineer (Electrical Engineering Team Lead)
2013-03-01 - 2018-10-01
NinePoint Medical, Inc. Senior Electrical Engineer (Electrical Engineering Team Lead)
2012-03-01 - 2013-03-01
Ron Moulton 在 embecta 担任 Director, R&D-Electrical Engineering
Ron Moulton 在 embecta 的职位是 Director, R&D-Electrical Engineering
Ron Moulton 的电子邮件地址是 ema***@***.com
Ron Moulton 的电话号码是 -
Ron Moulton 的公司电话号码是 +120****
Ron Moulton 在 medical devices 工作。
Ron Moulton 的一些同事包括Avital Merl-Margulies、Larry Cajucom、Nadia Baker、Giuseppe TomasiniCindy Shi、。
Ron Moulton联系方式： 电子邮件地址：ema***@***.com 电话号码：-
Ron Moulton 的个人领英是：http://www.linkedin.com/in/ron-moulton
Ron Moulton 的办公地点：parsippany-troy hills, new jersey, united states
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd
Sign Up with Google
